Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0VN7G
|
||||
Former ID |
DNC005009
|
||||
Drug Name |
Hexahydro-pyrrolizin-(3E)-ylideneamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527210] | ||
Structure |
Download2D MOL |
||||
Formula |
C7H12N2
|
||||
Canonical SMILES |
C1CC2CCC(=N)N2C1
|
||||
InChI |
1S/C7H12N2/c8-7-4-3-6-2-1-5-9(6)7/h6,8H,1-5H2
|
||||
InChIKey |
IGTGCXXJCCYMRS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric-oxide synthase, brain | Target Info | Inhibitor | [527210] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arginine and Proline Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.